Want to join the conversation?
During 3Q15, total revenue for $DNB was $414.2MM, up 8% vs. 3Q15 as growth in revenue was driven by acquisitions. Organic revenue was flat mainly due to sales execution issues in government & midsize customer channel and revenues being deferred as sales being shifted to newer embedded products where revenue is recognized over time.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?